JACC. Advances
Empagliflozin in Heart Failure and Previous Coronary Revascularization: Insights From EMPEROR-Pooled.
Nitish K Dhingra, Javed Butler, Stefan D Anker, Joao Pedro Ferreira, Gerasimos Filippatos, Egon Pfarr, Tomasz Gasior, Matias Nordaby, Martina Brueckmann, Stuart J Pocock, Faiez Zannad, Milton Packer, Subodh Verma, EMPEROR-Pooled Trial Committees and Investigators
Published: 202610.1016/j.jacadv.2025.102419
Abstract
BACKGROUND: Sodium glucose co-transporter-2 inhibitors are a foundational therapy for the management of chronic heart failure (HF). OBJECTIVES: The purpose of this study was to investigate whether the efficacy of sodium glucose co-transporter-2 inhib…
Preview only. Read the full abstract at the source